Abstract

The effects of the combined formulation Cytoflavin and its individual components (meglumine sodium succinate, nicotinamide, riboflavin, and inosine) on depressive behavioral disorders (DBD) were studied in mice with alloxan diabetes. Cytoflavin was found to be effective in correcting deficits in the activity of animals in the open field test and significantly reduced “despair behavior” in a 6-min tail suspension test; it also produced a transient hypoglycemic effect. The DBD-correcting activity of Cytoflavin was shown to be associated mainly with meglumine sodium succinate. The effect was significantly less linked with nicotinamide, which also produced the transient hypoglycemic action of Cytoflavin. Riboflavin made an even smaller contribution to the positive psychotropic action of Cytoflavin. The most problematic component of Cytoflavin was inosine, courses of which significantly increased lethality in mice with alloxan diabetes. However, this effect of inosine was only apparent when used alone, and disappeared completely when used in Cytoflavin.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call